Crossject
Develops emergency medications delivered via a needle-free auto-injector platform.
ALCJ | PA
Overview
Corporate Details
- ISIN(s):
- FR0004178614 (+6 more)
- LEI:
- 969500W1VTFNL2D85A65
- Country:
- France
- Address:
- 6 Rue Pauline Kergomard, 21000 dijon
- Website:
- https://www.crossject.com/en
- Sector:
- Manufacturing
Description
Crossject is a specialty pharmaceutical company focused on developing and commercializing medications for life-threatening emergency situations. The company's core technology is ZENEO®, a proprietary, pre-filled, single-use needle-free auto-injector. This platform is designed to enable patients or untrained caregivers to rapidly, safely, and reliably administer emergency treatments. Crossject's product pipeline targets critical conditions such as epileptic seizures, acute adrenal crisis, and severe allergic reactions (anaphylaxis), aiming to improve patient outcomes by simplifying drug delivery in urgent scenarios.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-09 18:00 |
CROSSJECT - Modification du calendrier financier
|
French | 137.8 KB | ||
| 2023-03-06 18:00 |
CROSSJECT - Bilan semestriel du contrat de liquidité au 31 décembre 2022
|
French | 300.1 KB | ||
| 2023-02-06 19:56 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 162.7 KB | ||
| 2023-02-06 19:50 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 155.1 KB | ||
| 2023-02-06 19:40 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 153.4 KB | ||
| 2023-02-06 18:29 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 150.3 KB | ||
| 2023-02-06 18:16 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 139.7 KB | ||
| 2023-02-01 18:00 |
CROSSJECT - CALENDRIER FINANCIER 2023
|
French | 156.5 KB | ||
| 2023-01-09 08:00 |
CROSSJECT - NOUVEAU RENFORCEMENT DE LA STRUCTURE FINANCIERE - Mise en place de …
|
French | 195.4 KB | ||
| 2022-11-07 18:00 |
CROSSJECT - Forte progression de la notation sociétale et environnementale Gaïa…
|
French | 248.5 KB | ||
| 2022-11-07 18:00 |
CROSSJECT - Big improvement in the Gaïa social and environmental rating - Furth…
|
English | 241.7 KB | ||
| 2022-11-02 08:00 |
CROSSJECT - CLINICAL DEMONSTRATION OF ZENEO® EFFICIENCY FOR INTRAMUSCULAR INJEC…
|
English | 280.2 KB | ||
| 2022-11-02 08:00 |
CROSSJECT - Validation clinique de l’efficacité de ZENEO® pour l’injection intr…
|
French | 271.8 KB | ||
| 2022-10-26 08:00 |
Très vif succès de l’augmentation de capital d’un montant de 4,09 M€ - Demande …
|
French | 408.1 KB | ||
| 2022-10-03 08:00 |
Crossject : Lancement d’une augmentation du capital avec maintien du droit préf…
|
French | 280.0 KB |
Automate Your Workflow. Get a real-time feed of all Crossject filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Crossject
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Crossject via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-06-24 | N/A | Other | Buy | 20,000 | N/A |
| 2024-06-14 | N/A | Other | Other | 10,979 | 20,289.19 EUR |
| 2024-06-06 | N/A | Other | Other | 1,058,617 | 1,956,324.22 EUR |
| 2024-06-06 | N/A | Other | Other | 16,106 | 29,763.89 EUR |
| 2024-06-06 | N/A | Other | Other | 10,275 | 18,988.20 EUR |
| 2024-06-06 | N/A | Other | Other | 10,074 | 18,616.75 EUR |
| 2024-06-06 | N/A | Other | Buy | 5,536 | 10,230.53 EUR |
| 2023-03-06 | N/A | Other | Other | 22,859 | 75,434.70 EUR |
Peer Companies
